Storystream | TEKGROUP Online Newsroom Software



Storystream


Jul 28, 2022

1:57:00 PM ET — via Ameriprise Financial
Advisor with Nearly $150 Million in Assets Joins Ameriprise For Client-Centric Culture and Industry-Leading Technology


10:00:00 AM ET — via Vizient
Vizient Projects 3.26% Drug Price Inflation Rate for 2023 in Latest Pharmacy Market Outlook

Vizient, Inc. released its Summer 2022 Pharmacy Market Outlook forecasting a 3.26% overall drug price inflation rate for the calendar year beginning Jan. 1, 2023. The rate reflects a continued trend toward moderation of the overall increase in drug prices, a result of the balance between the increased use of high-cost medications, the introduction of lower-cost generic drugs and greater utilization of biosimilars.


Jul 27, 2022

12:22:00 PM ET — via University Hospitals
UH Ahuja Medical Center To Host Two-Day Camp


10:45:00 AM ET — via Lincoln Financial
Lincoln Financial Group Named to Forbes List of Best Employers for Women


8:07:00 AM ET — via AbbVie
AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ®) in Crohn's Disease

NORTH CHICAGO, Ill., July 27, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that it has submitted applications for a new indication to the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) for upadacitinib (RINVOQ®, 45 mg [induction dose] and 15 mg and 30 mg [maintenance dose]) for the treatment of adult patients with moderately to severely active Crohn's disease.4,11


12:29:00 AM ET — via Accenture
Hero MotoCorp Selects Accenture for Supply Chain Transformation
NEW DELHI, India; July 27, 2022 – Accenture (NYSE: ACN) has been selected by Hero MotoCorp Ltd. (NSE: HEROMOTOCO), the world’s largest manufacturer of motorcycles and scooters, to scale up and enhance its future-ready supply chain.


Jul 26, 2022

4:01:00 PM ET — via TI
TI reports second quarter 2022 financial results and shareholder returns
Conference call on TI website at 3:30 p.m. Central time today
www.ti.com/ir


3:55:00 PM ET — via Ameriprise Financial
Ameriprise Financial Reports Second Quarter 2022 Results


3:53:00 PM ET — via Ameriprise Financial
Ameriprise Financial Declares Regular Quarterly Dividend
MINNEAPOLIS – July 26, 2022 – The Board of Directors of Ameriprise Financial, Inc. (NYSE: AMP) has declared a quarterly cash dividend of $1.25 per common share payable on August 19, 2022 to shareholders of record at the close of business on August 8, 2022.


2:48:00 PM ET — via Delaware North
Jackie Robinson Foundation selects Delaware North to operate retail store at soon-to-open Jackie Robinson Museum in New York City


8:59:00 AM ET — via Accenture
Most Companies Struggling to be Relevant to Their Customers, Accenture Report Finds
NEW YORK; July 26, 2022 – The vast majority (88%) of executives1 believe that customers and employees are changing faster than they can change their businesses, which is leading to a crisis of relevance, according to a new report from Accenture (NYSE: ACN).  


7:38:00 AM ET — via University Hospitals
U.S. News & World Report Again Names UH Cleveland Medical Center Among Nation's Best Hospitals for 2022-2023


6:35:00 AM ET — via MGM Resorts
BELLAGIO DEBUTS ONE OF A KIND IMMERSIVE DINING EXPERIENCE WITHIN ICONIC CONSERVATORY

LAS VEGAS (July 26, 2022) – The iconic Bellagio Conservatory & Botanical Gardens unveiled one of Las Vegas' most exclusive dining experiences with the debut of The Garden Table. Available for brunch or dinner, The Garden Table invites guests to enjoy an epicurean adventure at a table set within the spectacular beauty of Bellagio's stunning floral masterpiece. Specialty pre-fixe menus crafted by the award-winning teams at MICHAEL MINA Bellagio and Sadelle's Café feature fare that will delight all the senses.


2:07:00 AM ET — via AbbVie
European Commission Approves RINVOQ® (upadacitinib) for the Treatment of Adults With Moderate to Severe Ulcerative Colitis

NORTH CHICAGO, Ill., July 26, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the European Commission (EC) approved RINVOQ® (upadacitinib 45 mg [induction dose] and 15 mg and 30 mg [maintenance doses]) for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.*


1:00:00 AM ET — via National Peanut Board
The Peanut Podcast: Innovators in Peanuts
In the peanut industry, there are always advancements in the works. You'll find talented and dedicated people creating single origin peanut products, organic peanut farming or even mapping the genome of this legume. Innovators are on the forefront of pushing peanuts to new limits. The National Peanut Board (NPB) covered the topic in a recent episode of The Peanut Podcast. Read below for highlights and listen to the episode here or on your favorite streaming platform.


Jul 25, 2022

3:04:00 PM ET — via Ameriprise Financial
The Fed and Q2 GDP are on Deck This Week—How Might Stocks React
Stocks closed last week higher for the second time in three weeks. The S&P 500 Index jumped +2.6%, while the NASDAQ Composite finished the week higher by +3.3%. Despite risk-off trading on Friday, the S&P 500 ended the week back above its 50-day moving average. Not since April has the Index been able to trade above its short-term trading trend. In addition, the Dow Jones Industrials Average finished up nearly +2.0%.


2:14:00 PM ET — via Accenture
Accenture Acquires Solvera Solutions to Grow Digital Transformation Capabilities in Western Canada
TORONTO; July 25, 2022 – Accenture (NYSE: ACN) has acquired Solvera Solutions, a Regina-based company delivering platform-led digital transformation services across Western Canada. Financial terms of the transaction were not disclosed.


1:09:00 PM ET — via University Hospitals
Cleveland Clinic and University Hospitals Launch New Accelerator Program to Support Economic Equity and Growth for Local Diverse Suppliers


12:33:00 PM ET — via University Hospitals
Nominations Open for 10th Annual International Harrington Prize for Innovation in Medicine


previous next

You must be logged in to view this item.



Login

This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.